Blog

U.S. stock futures ticked up early Monday as investors welcomed signs of a possible easing in trade frictions between Washington and Beijing. Meanwhile, fresh data shows the iPhone 17 from Apple (NASDAQ:AAPL) is selling faster than last year’s model in the U.S. and China, and Kering (EU:KER) has struck a €4 billion deal to hand over its beauty unit to L’Oréal (EU:OR).

U.S. futures move higher

Wall Street looks set to open in the green as traders monitor early signs of a thaw in U.S.-China relations and prepare for a big week of earnings reports.

By 03:28 ET, Dow futures were up 176 points (+0.4%), S&P 500 futures climbed 30 points (+0.5%), and Nasdaq 100 futures gained 139 points (+0.6%).

All three major indexes closed the previous week higher. President Donald Trump said his plan for triple-digit tariffs on Chinese imports is “not sustainable,” even as he criticized Beijing for tightening restrictions on rare earth exports.

Trump confirmed he will meet Chinese President Xi Jinping in South Korea later this month, saying in a TV interview that the U.S. is “going to be fine with China.”

Treasury Secretary Scott Bessent also said he will meet Chinese Vice Premier He Lifeng this week in an effort to cool tensions. Chinese state media reported that He and Bessent held “constructive discussions” and agreed to resume trade talks “as soon as possible.”

Despite the softer tone, tariffs remain a core policy weapon for the White House. Trump pledged to keep “massive” tariffs on India in place until it halts purchases of Russian oil and hinted at increased tariffs on Colombia.

Investors will also be keeping an eye on results from Tesla (NASDAQ:TSLA) and Netflix (NASDAQ:NFLX), as well as an inflation report delayed by the U.S. government shutdown.

iPhone 17 outpaces iPhone 16

Sales of Apple’s iPhone 17 series have outstripped those of the iPhone 16 by 14% during the first 10 days of availability in the U.S. and China, according to Counterpoint Research.

The base model has been the standout, with sales jumping nearly one-third compared to last year’s entry-level iPhone. Chinese consumers have shown particularly strong demand, with unit sales almost doubling from a year ago.

“The base model iPhone 17 is very compelling to consumers, offering great value for money,” said Mengmeng Zhang, Senior Analyst at Counterpoint. She added that the model delivers “a better chip, improved display, higher base storage, selfie camera upgrade — all for the same price as last year’s iPhone 16.”

In the U.S., the iPhone 17 Pro Max has been the top seller, helped by carriers raising maximum subsidies by 10%, a move interpreted as a push toward high-spending customers.

Kering to sell beauty business to L’Oréal in €4B deal

Kering announced plans to sell its fragrance house Creed to L’Oréal in a €4 billion all-cash transaction.

The deal also includes licensing rights for brands such as Gucci, Balenciaga and Bottega Veneta. Once approved by regulators, L’Oréal will gain exclusive rights to produce and distribute beauty products for these labels for 50 years, starting in the first half of 2026.

The companies also announced a 50/50 joint venture aimed at exploring “new business opportunities at the intersection of luxury, wellness, and longevity.”

“This partnership allows us to focus on what defines us best: the creative power and desirability of our Houses,” said Kering CEO Luca de Meo.

Kering shares climbed more than 4% in early European trading, while L’Oréal gained nearly 1%.

China’s growth slows but beats forecasts

China’s economy expanded slightly more than expected in the third quarter of 2025, though growth slowed to its weakest pace in a year as disinflation and trade tensions weighed.

GDP rose 4.8% year-on-year, just above expectations of 4.7% but down from 5.2% in the previous quarter. On a quarterly basis, growth came in at 1.1%, above the 0.8% forecast.

Year-to-date GDP stood at 5.2%, a touch lower than the 5.3% recorded last quarter but still above Beijing’s 5% annual target.

Gold steadies near record highs

Gold prices edged higher Monday, clawing back some losses from last week while remaining close to all-time highs as investors digested a softer U.S. tone on China trade.

Spot gold rose 0.2% to $4,257.09 an ounce, while December futures gained 1.4% to $4,270.69/oz by 03:54 ET.

The metal retreated from record levels last week after Trump questioned the durability of the trade war with Beijing but confirmed talks are still on track. The shift in tone reduced some of the safe-haven demand that had recently fueled bullion’s rally.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.

Gold prices moved up in Asian trading on Monday, trimming part of last week’s steep losses as investors responded to a more conciliatory tone from U.S. officials on trade relations with China. The precious metal also remained close to recent record levels.

Spot gold rose 0.4% to $4,267.70 an ounce, while December gold futures climbed 1.6% to $4,280.65 per ounce as of 00:49 ET (05:49 GMT). Spot prices had touched a record $4,379.44 last week before retreating.

Gold slips from record highs after U.S.-China tensions ease

The metal saw heavy selling last week after U.S. President Donald Trump downplayed the likelihood of a prolonged trade conflict with China and confirmed that negotiations were still moving forward. Trump said he viewed high tariffs on China as “not sustainable” and announced plans to meet Chinese President Xi Jinping in South Korea in two weeks.

Additionally, U.S. Treasury Secretary Scott Bessent confirmed that further discussions with Chinese officials were scheduled for this week. These comments boosted sentiment across financial markets, prompting investors to rotate out of safe-haven assets such as gold and into risk-sensitive instruments.

The retreat in gold was also amplified by profit-taking following a powerful two-month rally. The metal had been supported by mounting concerns over the U.S. economy amid a government shutdown and growing expectations of additional interest rate cuts by Federal Reserve System.

Safe-haven demand continues amid geopolitical risks

Gold’s gains on Monday were further underpinned by heightened geopolitical uncertainty. Tensions flared in the Israel-Hamas ceasefire over the weekend, though Israel signaled the truce remained intact and humanitarian aid to Gaza would resume.

Meanwhile, global attention turned to U.S. efforts to broker a ceasefire in the Russia-Ukraine conflict. Trump reportedly met with Ukrainian President Volodymyr Zelensky and urged Kyiv to cede territory to Moscow, while also declining additional military support.

These developments, coupled with economic worries in the U.S., helped sustain demand for safe-haven assets, including gold and other precious metals.

Spot silver gained 0.6% to $52.2520 an ounce, hovering near its own all-time high, while spot platinum fell 1% to $1,597.02.

In the industrial metals segment, copper prices advanced after positive economic data from China, the world’s largest importer. The country’s GDP grew slightly faster than expected in the third quarter, though it was still the slowest expansion in a year.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.

Oil prices moved lower on Monday as renewed U.S.-China trade frictions amplified concerns about a potential global oversupply, slowing growth, and weakening energy demand.

At 00:32 GMT, Brent crude futures slipped 24 cents, or 0.4%, to $61.05 a barrel, while U.S. West Texas Intermediate futures were down 21 cents, or 0.4%, at $57.33, giving up Friday’s modest gains.

Both benchmarks posted declines of more than 2% last week, their third consecutive weekly drop, weighed down in part by International Energy Agency forecasts pointing to a growing surplus in 2026.

“Concerns about oversupply from increased production by oil-producing nations, coupled with fears of an economic slowdown stemming from escalating U.S.-China trade tensions, are fuelling selling pressure,” said Toshitaka Tazawa, an analyst at Fujitomi Securities.

“While the U.S. is stepping up pressure on buyers of Russian crude, the upcoming summit between U.S. President Donald Trump and Russian President Vladimir Putin adds uncertainty to the outlook, making it difficult for some investors to adjust their positions,” he said.

Last week, the head of the World Trade Organization urged Washington and Beijing to ease trade tensions, warning that decoupling between the two largest economies could shrink global output by 7% over time.

The world’s two biggest oil consumers have recently reignited their trade dispute, imposing reciprocal port fees on cargo shipments, a move that could disrupt global shipping flows.

Meanwhile, Trump and Putin agreed on Thursday to hold another summit on the war in Ukraine, even as Washington ramped up pressure on India and China to curb Russian oil purchases.

After meeting with Ukrainian President Volodymyr Zelenskiy at the White House on Friday, Trump called on both Ukraine and Russia to “stop the war immediately,” even if that requires Ukraine to give up territory.

Analysts and trade sources noted that U.S. and European pressure on Asian buyers of Russian energy could reduce India’s imports from December, potentially opening the door to cheaper supplies for China.

On the production side, Baker Hughes Company reported on Friday that U.S. energy companies added oil and natural gas rigs for the first time in three weeks, signaling a possible uptick in domestic output.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.

JPMorgan Chase & Co. strategists expect the third-quarter earnings season to once again emphasize the divergence between U.S. and eurozone corporate results, with consensus forecasts calling for a 6% year-on-year increase in S&P 500 earnings compared to a 1% decline for the STOXX Europe 600.

Analyst projections have remained stable leading up to earnings releases, unlike the usual trend of downward revisions. Strategists noted that “activity momentum improved during the quarter,” supported by firmer PMI data. The team, led by Mislav Matejka, also pointed out that this unusual stability in forecasts over the past two months “raises the potential for positive surprises.”

Roughly 60% of the S&P 500’s market capitalization is set to report over the next two weeks, compared with around 50% for European stocks. Mega-cap technology names remain the engine of U.S. earnings growth, with the so-called Magnificent 7 expected to deliver 15% earnings growth after a 27% surge last quarter—nearly double initial forecasts.

For the rest of the S&P 500, earnings are projected to grow around 4%. JPMorgan noted that non-Mag 7 companies achieved their strongest earnings expansion in three years last quarter at 9%, and strategists see room for similar upside this season.

Eurozone corporates, by contrast, saw a 1% earnings contraction in the previous quarter, reinforcing the bank’s cautious outlook for the region since March. Even so, strategists anticipate the gap with the U.S. may narrow “by a smaller magnitude” this quarter, thanks to exporter earnings that have already been heavily rebased, opening the door for a potential “inflection.”

Median earnings growth paints a more even picture, with both regions expected to post about 4% year-on-year gains, leaving room for upside surprises if revenue trends hold.

Revenue momentum remains a risk factor, however, with weaker Brent crude prices and softer U.S. labor and retail indicators hinting at potential top-line pressure. Lower bond yields—down more than 60 basis points from their peak—have boosted defensive sectors like Utilities and Healthcare over the past one to three months in both the U.S. and Europe.

Strategists say this supports their long-duration positioning, but they also stress that “cyclicals sector earnings could start to look better” heading into 2026 as economic activity improves. They cite rising PMI readings, stronger credit impulses in Europe, and better consumer sentiment and liquidity conditions.

Looking further ahead, JPMorgan sees cyclical sectors benefiting from improving macroeconomic trends, including a potential rebound in Chinese consumer demand, which could lift luxury and industrial companies. While eurozone earnings forecasts for 2025 are still being revised downward, 2026 estimates suggest a rebound of nearly 15%, driven by favorable base effects and stronger domestic and external demand.

“We are now bullish Eurozone, post the sideways trading and amid a range of pushbacks,” the strategists wrote.

“If the latest tariff standoff and credit concerns result in some more equity weakness, we do not think Eurozone needs to be a beta on the way down, given more favourable positioning and valuations, and given an already weak recent relative performance,” they added.

They also reiterated their view that the recent political turbulence in France should be treated as a buying opportunity.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.

European markets started the week on a strong footing Monday, buoyed by sharp gains across Asia and ahead of a heavy schedule of corporate earnings.

By 07:10 GMT, Germany’s DAX was up 1%, France’s CAC 40 rose 0.5%, and the U.K.’s FTSE 100 climbed 0.4%. This followed a weak close on Friday, when worries surrounding the U.S. banking sector dragged European indices lower. A late rebound in U.S. regional banks helped ease those concerns going into the new week.

Nikkei Jumps on Political Developments

European sentiment was bolstered by a surge in Japanese stocks overnight. The Nikkei 225 soared more than 3% to surpass 49,000 points, hitting a record high after reports that Japan’s ruling Liberal Democratic Party secured enough parliamentary support to form a coalition government led by Sanae Takaichi.

Takaichi, widely seen as fiscally accommodative, is expected to support increased government spending and resist additional rate hikes from the Bank of Japan. Parliament is set to vote on her premiership on Tuesday, paving the way for Japan’s first female prime minister.

China’s Growth Slows but Beats Forecasts

In China, third-quarter GDP expanded by 4.8% year-on-year, slightly above market forecasts of 4.7% but slower than the 5.2% growth seen in the second quarter, according to official data released Monday. It marked the country’s slowest annual growth since Q3 2024, reflecting ongoing pressure from persistent disinflation and trade frictions with the U.S.

Meanwhile, in Europe, German producer prices slipped 0.1% in September, down 1.7% year-on-year, underscoring limited inflationary pressures in the eurozone’s largest economy.

Luxury Sector in Focus as Kering Sells Beauty Arm

The luxury sector is drawing attention after Kering (EU:KER) announced over the weekend that it would sell its beauty division to L’Oréal (EU:OR) for €4 billion. The deal reflects new CEO Luca de Meo’s strategy to reduce debt and refocus on the group’s fashion brands.

This week starts relatively quietly on the earnings front but will pick up pace in the coming days. L’Oréal reports Tuesday, while SAP (TG:SAP), Barclays (LSE:BARC) and Heineken (TG:HNK1) are scheduled for Wednesday. On Thursday, results from Kering, Roche (TG:RHO), Unilever (LSE:ULVR) and Lloyds Banking Group (LSE:LLOY) will be in focus.

In the U.S., major earnings this week include(NASDAQ:TSLA), Ford (NYSE:F), General Motors (NYSE:GM), Netflix (NASDAQ:NFLX), Procter & Gamble (NYSE:PG) and Coca-Cola (NYSE:KO), along with aerospace and defence giant RTX (NYSE:RTX) and tech stalwarts IBM (NYSE:IBM) and Intel (NASDAQ:INTC).

Oil Prices Slip as Supply Concerns Mount

Crude oil prices extended their decline Monday amid persistent concerns over weak demand and an expected supply surplus. Brent crude futures fell 0.8% to $60.83 a barrel, while U.S. West Texas Intermediate futures dropped 0.8% to $56.72.

Both benchmarks lost more than 2% last week, marking their third consecutive weekly decline, weighed down by the International Energy Agency’s warning of a looming supply glut in 2026.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.

LONDON, 20 October 2025 — Investa, the UK’s first zero-commission options trading app (other fees may apply), has announced the early access opening of its second crowdfunding campaign on Crowdcube, beginning Monday, 20 October.

The fintech startup is aiming to raise at least £1 million in this new round, building on the success of its 2024 Crowdcube campaign, which was overfunded by 220% and attracted nearly 500 investors. That raise became the most participated-in UK fintech campaign on the European equity crowdfunding platform last year, reaching its target within four hours and closing six days ahead of schedule.

Investa plans to use the funds from this latest campaign to accelerate its growth and product development, including launching its Android app, scaling customer acquisition, expanding trading infrastructure, and strengthening operations following the successful rollout of its iOS platform. The company also intends to continue enhancing accessibility and transparency in options trading for retail investors across the UK.

Early access registrants will have the opportunity to express investment interest ahead of the Private Live round, which takes place on 27–28 October. The campaign will then open to the public on 29 October.

Since completing its first fundraising round, Investa has launched its iOS app—achieving over 1,000 downloads on day one—and facilitated more than 2,000 stock and options trades. The platform now offers access to over 100,000 tradable options contracts and recently introduced Open Banking integration to simplify funding accounts. Investa was also named a finalist in the Wealth category at the 2025 FF Awards.

“The support we received from the Crowdcube community last year was phenomenal,” said Alec Beasley, Co-Founder and CEO of Investa. “It validated our mission to make options trading accessible to UK retail investors and showed that everyday traders want the same opportunities long enjoyed by professionals. With this next crowdfunding campaign, we’re building on that momentum to deliver the UK’s best options trading experience.”

Matt Cooper, Co-CEO of Crowdcube, added: “Investa’s 2024 fundraise was really well supported. The team’s mission to democratise options trading in the UK clearly resonated with investors. It’s exciting to back companies that are expanding financial inclusion and opening new pathways for retail participation.”

More information on the fundraise can be found on Investa’s Crowdcube page.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Kering (EU:KER) saw its stock rise about 5% on Monday after announcing the sale of its beauty division to L’Oréal (EU:OR) for €4 billion. The move marks a strategic shift under new CEO Luca de Meo, aiming to streamline operations and strengthen the company’s financial position.

The agreement includes the sale of luxury fragrance house Creed—acquired by Kering in 2023—and grants L’Oréal exclusive rights for 50 years to produce and market fragrance and beauty products for Gucci, Bottega Veneta and Balenciaga once existing licensing deals, including Gucci’s partnership with Coty Inc. (expiring in 2028), conclude.

This deal effectively unwinds one of the most ambitious diversification strategies launched by former CEO François-Henri Pinault, who established Kering Beauté to push the group further into the lucrative beauty sector traditionally dominated by licensing partnerships.

The divestment comes at a critical time for Kering. At the end of June, the group’s net debt stood at €9.5 billion, alongside €6 billion in lease liabilities. Slower growth at Gucci—which accounts for more than half of group profits—particularly in China, has heightened investor concern around leverage.

The integration of Creed and the launch of in-house perfume lines, such as Bottega Veneta fragrances, failed to deliver the expected boost, with the division still loss-making in the first half of 2025. By selling the business rather than expanding it, de Meo is clearly signaling a shift back to a leaner model centered on fashion, operational efficiency, and cash flow.

For L’Oréal, this transaction is equally transformative. It gives the cosmetics group direct control of Creed and, in time, Gucci fragrances—one of the most valuable names in the global beauty industry. This will be L’Oréal’s largest-ever acquisition, surpassing its $2.5 billion purchase of Aesop in 2023, and reinforces its expansion into luxury fragrances. The two companies will also create a joint venture focused on wellness and longevity, extending their strategic relationship beyond licensing.

Market analysts welcomed the deal. UBS said the €4 billion valuation would be “a small positive for Kering,” helping address balance sheet concerns that have weighed on the stock this year. Deleveraging has become a key investor focus, particularly after delays in the Valentino transaction, and the sale could offset any impairment linked to the Creed acquisition.

Bernstein described the move as “bitter but necessary medicine,” suggesting that stepping away from in-house beauty will allow de Meo to concentrate fully on turning around Gucci. Analysts noted that Creed remains one of the most attractive assets in luxury fragrance and that the sale price appeared strong, but shareholder priorities have shifted firmly toward repairing the balance sheet.

JPMorgan Chase & Co. called the deal “the first material act” of de Meo’s tenure and “a sharp change in strategy,” hinting at the possibility of further divestitures of lower-margin assets. While streamlining operations could be welcomed by investors, the bank warned that relinquishing long-term control of beauty may limit upside potential if Gucci fragrances outperform over time.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.

The FTSE 100 opened in positive territory on Monday, rising 0.4% by 07:20 GMT, supported by broad market gains across Europe. The pound edged slightly lower against the dollar but remained above $1.34, down 0.08%. European markets also advanced, with Germany’s DAX gaining 1.1% and France’s CAC 40 up 0.6%.

B&M Shares Sink After Guidance Cut and CFO Exit

Shares of B&M European Value Retail S.A. (LSE:BME) plunged more than 18% after the company cut its FY26 financial outlook due to a £7 million error in overseas freight cost recognition.

B&M now expects Group Adjusted EBITDA (pre-IFRS 16) between £470 million and £520 million for FY26, down from the previous range of £510 million to £560 million announced earlier this month. First-half FY26 EBITDA guidance has also been lowered to approximately £191 million from £198 million.

In a management shake-up, CFO Mike Schmidt announced his intention to step down, with a formal search underway for his successor. Schmidt will remain in his role until a smooth transition is completed.

Plus500 Beats Forecasts with Strong Q3

Plus500 (LSE:PLUS) posted stronger-than-expected Q3 2025 results, driven by robust growth in its U.S. futures business and consistent over-the-counter trading activity.

Revenue came in at $182.7 million, around 10% above consensus estimates of $165 million. Trading income accounted for $161.6 million, while interest income rose sharply to $21.1 million, up from $15 million in each of the previous two quarters. EBITDA reached $82.7 million, delivering a 45% margin — about 5% above implied market expectations, according to Jefferies.

GlobalData Reaffirms FY25 Revenue Outlook

GlobalData Plc (LSE:DATA) reaffirmed that its FY25 revenue is expected to be in line with market forecasts. The company reported 13.5% revenue growth in Q3, supported by an improvement in underlying subscription revenue growth from 1% in the first half to 2% in the third quarter, along with contributions from recent acquisitions.

Enhertu Delivers Positive Results in Breast Cancer Trials

AstraZeneca PLC (LSE:AZN) and Daiichi Sankyo Co., Ltd. (TG:D4S) announced that their cancer therapy Enhertu produced strong outcomes in two pivotal trials for early-stage breast cancer.

The data showed significant efficacy in treating a specific form of early-stage breast cancer, supporting the ongoing development and clinical testing of the drug by both companies.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.

Arc Minerals (LSE:ARCM) has announced the termination of its joint venture with Anglo American concerning its Zambian mining tenements. The decision follows a lack of drilling activity throughout 2025, with Anglo American withdrawing and relinquishing its interests.

As a result, Arc Minerals will regain full control of Handa Resources Limited and intends to explore new strategic options for the assets, including the potential engagement of a new joint venture partner. The company has stated that it remains financially stable, with no immediate requirement for an equity raise, and is focused on resolving outstanding legal matters in Zambia.

About Arc Minerals

Arc Minerals is an exploration company focused on advancing Tier 1 copper projects, with core operations in Zambia. Listed on the London Stock Exchange, the company holds a portfolio of highly prospective copper tenements across Africa.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.

Avacta Group plc (LSE:AVCT) has raised approximately £16 million through an oversubscribed equity placement, providing the company with additional working capital to support its research and development activities through the second half of 2026. The capital will fund the ongoing Phase 1b trial of faridoxorubicin and the launch of the FAP-EXd Phase Ia trial, while allowing Avacta to retain full ownership of its programs built on its proprietary pre|CISION® technology platform.

This funding round also enables the deferment of certain convertible bond repayments, effectively extending the company’s cash runway and supporting further development of its intellectual property portfolio.

Although Avacta faces financial pressures linked to weak earnings, technical indicators offer some near-term optimism. Valuation remains challenging, but the strategic progress highlighted in recent communications demonstrates continued advancement in its oncology pipeline.

About Avacta Group plc

Avacta Group is a clinical-stage life sciences company pioneering pre|CISION®, a proprietary drug delivery platform designed to improve oncology treatments by reducing toxicity and targeting drug release directly within tumors. Its technology uses peptide drug conjugates (PDCs) to enhance drug efficacy and patient tolerability.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.